202 related articles for article (PubMed ID: 38142874)
1. Engineered liposomes mediated approach for targeted colorectal cancer drug Delivery: A review.
Shazleen Ibrahim I; Starlin Chellathurai M; Mahmood S; Hakim Azmi A; Harun N; Ulul Ilmie Ahmad Nazri M; Muzamir Mahat M; Mohamed Sofian Z
Int J Pharm; 2024 Feb; 651():123735. PubMed ID: 38142874
[TBL] [Abstract][Full Text] [Related]
2. Liposome technologies towards colorectal cancer therapeutics.
Sang R; Stratton B; Engel A; Deng W
Acta Biomater; 2021 Jun; 127():24-40. PubMed ID: 33812076
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer management: strategies in drug delivery.
Singh P; Waghambare P; Khan TA; Omri A
Expert Opin Drug Deliv; 2022 Jun; 19(6):653-670. PubMed ID: 35656670
[TBL] [Abstract][Full Text] [Related]
4. Micelles as potential drug delivery systems for colorectal cancer treatment.
Fatfat Z; Fatfat M; Gali-Muhtasib H
World J Gastroenterol; 2022 Jul; 28(25):2867-2880. PubMed ID: 35978871
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticles: The future of effective diagnosis and treatment of colorectal cancer?
Naeimi R; Najafi R; Molaei P; Amini R; Pecic S
Eur J Pharmacol; 2022 Dec; 936():175350. PubMed ID: 36306928
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticles: Attractive tools to treat colorectal cancer.
Younis NK; Roumieh R; Bassil EP; Ghoubaira JA; Kobeissy F; Eid AH
Semin Cancer Biol; 2022 Nov; 86(Pt 2):1-13. PubMed ID: 36028154
[TBL] [Abstract][Full Text] [Related]
7. Functionalized FcRn-targeted nanosystems for oral drug delivery: A new approach to colorectal cancer treatment.
Hameedat F; Pizarroso NA; Teixeira N; Pinto S; Sarmento B
Eur J Pharm Sci; 2022 Sep; 176():106259. PubMed ID: 35842140
[TBL] [Abstract][Full Text] [Related]
8. Relationship Between Increased Fucosylation and Metastatic Potential in Colorectal Cancer.
Osuga T; Takimoto R; Ono M; Hirakawa M; Yoshida M; Okagawa Y; Uemura N; Arihara Y; Sato Y; Tamura F; Sato T; Iyama S; Miyanishi K; Takada K; Hayashi T; Kobune M; Kato J
J Natl Cancer Inst; 2016 Sep; 108(9):. PubMed ID: 27628655
[TBL] [Abstract][Full Text] [Related]
9. Targeted nanoparticles for colorectal cancer.
Cisterna BA; Kamaly N; Choi WI; Tavakkoli A; Farokhzad OC; Vilos C
Nanomedicine (Lond); 2016 Sep; 11(18):2443-56. PubMed ID: 27529192
[TBL] [Abstract][Full Text] [Related]
10. Recent progress of targeted nanocarriers in diagnostic, therapeutic, and theranostic applications in colorectal cancer.
Choudhury H; Pandey M; Saravanan V; Mun ATY; Bhattamisra SK; Parikh A; Garg S; Gorain B
Biomater Adv; 2023 Oct; 153():213556. PubMed ID: 37478770
[TBL] [Abstract][Full Text] [Related]
11. Basics to advances in nanotherapy of colorectal cancer.
Tiwari A; Saraf S; Jain A; Panda PK; Verma A; Jain SK
Drug Deliv Transl Res; 2020 Apr; 10(2):319-338. PubMed ID: 31701486
[TBL] [Abstract][Full Text] [Related]
12. Nano-Drug Delivery Systems Based on Different Targeting Mechanisms in the Targeted Therapy of Colorectal Cancer.
Wang K; Shen R; Meng T; Hu F; Yuan H
Molecules; 2022 May; 27(9):. PubMed ID: 35566331
[TBL] [Abstract][Full Text] [Related]
13. Engineered nanoparticles for imaging and drug delivery in colorectal cancer.
Pavitra E; Dariya B; Srivani G; Kang SM; Alam A; Sudhir PR; Kamal MA; Raju GSR; Han YK; Lakkakula BVKS; Nagaraju GP; Huh YS
Semin Cancer Biol; 2021 Feb; 69():293-306. PubMed ID: 31260733
[TBL] [Abstract][Full Text] [Related]
14. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
15. Liposomes as Delivery System of a Sn(IV) Complex for Cancer Therapy.
Corvo ML; Mendo AS; Figueiredo S; Gaspar R; Larguinho M; Guedes da Silva MF; Baptista PV; Fernandes AR
Pharm Res; 2016 Jun; 33(6):1351-8. PubMed ID: 27033349
[TBL] [Abstract][Full Text] [Related]
16. Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer.
Zalba S; Contreras AM; Haeri A; Ten Hagen TL; Navarro I; Koning G; Garrido MJ
J Control Release; 2015 Jul; 210():26-38. PubMed ID: 25998052
[TBL] [Abstract][Full Text] [Related]
17. Relationship Between Increased Fucosylation and Metastatic Potential in Colorectal Cancer.
Osuga T; Takimoto R; Ono M; Hirakawa M; Yoshida M; Okagawa Y; Uemura N; Arihara Y; Sato Y; Tamura F; Sato T; Iyama S; Miyanishi K; Takada K; Hayashi T; Kobune M; Kato J
J Natl Cancer Inst; 2016 Aug; 108(8):. PubMed ID: 27075853
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in nanomedicine preparative methods and their therapeutic potential for colorectal cancer: a critical review.
Jain A; Bhattacharya S
Front Oncol; 2023; 13():1211603. PubMed ID: 37427139
[TBL] [Abstract][Full Text] [Related]
19. Insight on nano drug delivery systems with targeted therapy in treatment of oral cancer.
Vyas K; Rathod M; Patel MM
Nanomedicine; 2023 Apr; 49():102662. PubMed ID: 36746272
[TBL] [Abstract][Full Text] [Related]
20. New Trends in Liposome-based Drug Delivery in Colorectal Cancer.
Krajewska JB; Bartoszek A; Fichna J
Mini Rev Med Chem; 2019; 19(1):3-11. PubMed ID: 30179131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
